Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 465Terminated 112Recruiting 108Unknown 102Active not recruiting 59Withdrawn 35Not yet recruiting 18Enrolling by invitation 3Suspended 2No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 3Neoplasm, Residual 1

Interventions

Cytarabine 3venetoclax 2fludarabine 2olverembatinib 1ibrutinib 1fludarabine phosphate 1decitabine and cedazuridine drug combination 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1Surveys and Questionnaires 1Ropivacaine 1Platelet Transfusion 1Melphalan 1Maintenance 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Lenalidomide 1JNJ-64619178 1JNJ-64264681 1Inosine Monophosphate 1Imatinib Mesylate 1Dexamethasone 1Daunorubicin 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Cytarabine × Other hematologic neoplasm × Clear all
NCT07537257 2026-04-17

VEN+IDAC vs IDAC in AML

Guangdong Second Provincial General Hospital

Phase 2/3 Enrolling by invitation
232 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT06697327 2025-05-14

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

Anhui Medical University

Phase NA Enrolling by invitation
94 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03507842 2025-03-17

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Asan Medical Center

Phase 3 Enrolling by invitation
380 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡